Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 2, 1996, Pages 169-177

  Teicher, Beverly A ^a   Holden, Sylvia A ^a   Ara, Gulshan ^a   Korbut, Timothy ^a   Menon, Krishna ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

antiangiogenic agents; combination therapy; genistein; minocycline; suramin; TNP 470

Indexed keywords

ANGIOGENESIS INHIBITOR; BETA CYCLODEXTRIN DERIVATIVE; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FUMAGILLOL CHLOROACETYLCARBAMATE; GENISTEIN; INTERFERON DELTA4; MINOCYCLINE; SURAMIN; TETRAHYDROCORTISOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEWIS CARCINOMA; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LEWIS LUNG; CELL SURVIVAL; DRUG SYNERGISM; LUNG NEOPLASMS; MALE; MICE; TUMOR CELLS, CULTURED;

EID: 0029971486     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050466     Document Type: Article

References (122)

1. Aaltoma S, Lipponen P (1992) Prognostic factors in breast cancer (review). Int J Oncol 1: 153
2. Alexander CM, Werb Z (1989) Proteinases and extracellular matrix remodelling. Curr Opin Cell Biol 1: 974
3. Alvarez Sotomayor E, Teicher BA, Schwartz GN, Holden SA, Menon K, Herman TS, Frei E III (1992) Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo. Cancer Chemother Pharmacol 30: 377
4. Aman MJ, Rudolf G, Goldschmitt J, Aulitzky WE, Lam C, Huber C, Peschel C (1993) Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells. Blood 82: 2371
5. Baggiolini M, Clark-Lewis I (1992) Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 307: 97
6. Baird A, Ling A (1987) Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophys Res Commun 142: 428
7. Barnes S, Grubbs C, Setchell KDR, Carlson J (1990) Soybeans inhibit mammary tumor in models of breast cancer. In: Pariza M, Liss AR (eds) Mutagens and carcinogens in the diet. Wiley-Liss, New York, p 239
8. Bickel M (1993) The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontal Res 64: 456
9. Bicknell R, Vallee BL (1989) Angiogenin stimulates endothelial cell prostacyclin secretion by activation of phospholipase. Proc Natl Acad Sci USA 86: 1573
10. Bogden AE, Taylor JE, Moreau J-P, Coy DH, LePage DJ (1990) Response of human lung tumor xenografts to treatment with a somatostatin analogue (somatuline). Cancer Res 50: 4360
11. Brem H, Folkman J (1993) Analysis of experimental antiangiogenic therapy. J Pediate Surg 28: 445
12. Brem H, Ingber D, Blood CH, Bradley D, Urioste S, Folkman J (1991) Suppression of tumor metastasis by angiogenesis inhibition. Surg Forum 42: 439
13. Brem H, Gresser I, Grossfeld J, Folkman J (1993) The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Pediate Surg 28: 445
14. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA, Thomas KA (1990) Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87: 2628
15. Conn G, Soderman DD, Schaeffer MT, Wile M, Hatcher VB, Thomas KA (1990) Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 87: 1323
16. Connolly JL, Ducatman BS, Schnitt SJ, Dvorak AM, Dvorak HF (1993) Principles of cancer pathology. In: Holland JF, Frei III E, Bast RC Jr, Kufe DW, Morton DL, Weichselbaum RR (eds) Cancer medicine. Lea & Febiger, Philadelphia, p 432
17. Constantinou A, Kiguchi K, Huberman E (1990) Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res 50: 2618
18. Corcoran ML, Stetler-Stevenson WG, Brown PD, Wahl LM (1992) Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagense/gelatinase production by human monocytes. J Biol Chem 267: 515
19. Cotran RS, Kumar V, Robbins SL (1989) Neoplasia. In: Robbins' pathologic basis of disease. W.B. Saunders, Philadelphia, p 239
20. Danesi R, Del Bianchi S, Soldani P, Campagni A, La Rocca RV, Myers CE, Paparelli A, Del Tacca M (1993) Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane. Br J Cancer 68: 932
21. DeClerck YA (1988) Purification and characterization of a collagenase inhibitor produced by bovine vascular smooth muscle cells. Arch Biochem Biophys 265: 28
22. Derynck R (1990) Transforming growth factor-alpha. Mol Reprod Dev 27: 3
23. Dickson RB, Lippman ME (1992) Molecular determinants of growth, angiogenesis, and metastases in breast cancer. Semin Oncol 19: 286
24. Dobson DE, Kambe A, Block E, Dion T, Lu H, Castellot JJ Jr, Spiefelman BM (1990) 1-Butyryl-glycerol: a novel angiogenesis factor secreted by differentiating adipocytes. Cell 61: 223
25. Dusseau JW, Hutchins PM, Malbasa DS (1986) Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane. Circ Res 59: 163
26. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. New Engl J Med 315: 1650
27. Ezekowitz RAB, Phil D, Mulliken JB, Folkman J (1992) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. New Engl J Med 326: 1456
28. Folkman J (1987) What is the role of angiogenesis in metastasis from cutaneous melanoma? Eur J Cancer Clin Oncol 23: 361
29. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4
30. Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235: 442
31. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267: 10931
32. Folkman J, Watson K, Ingber D, Hanahan D (1989) Induction of angiogenesis during the transition from hyperplasis to neoplasia. Nature 339: 58
33. Folkman J, Weisz PB, Joullie MM, Li WW, Ewing WR (1989) Control of angiogenesis with synthetic heparin substitutes. Science 243: 1490
34. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90: 2690
35. Gasparini G, Gullick WJ, Bevilacqua P, Pozza F, Lemoine NR, Meli S, Boracchi P, La Malfa G, Weidner N (1993) Pathobiological characteristics of the first primary and risk of metachronous contralateral invasive breast carcinoma: clinical implications. Int J Oncol 2: 781
36. Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS (1987) A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dent Res 66: 1310
37. Golub LM, Ramamurthy NS, McNamara TF, Grenwald RA, Rifkin BR (1991)Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 2: 297
38. Gospodarowicz D (1990) Fibroblast growth factor and its involvement in developmental processes. Curr Top Dev Biol 24: 57
39. Graeber JE, Glaser BM, Setty BNY, Jerdan JA, Walega RW, Stuart MJ (1990) 15-Hydroxyeicosatetraenoic acid stimulates migration of human retinal microvessel endothelium in vitro and neovascularization in vivo. Prostaglandins 39: 665
40. Greenwald RA, Golub LM, Lavietes B, Ramamurthy NS, Bruber B, Laskin RS, McNamara TF (1987) Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol 14: 28
41. Groopman JE, Scadden DT (1989) Interferon therapy for Kaposi sarcoma associated with the acquired immunodeficiency-syndrome (AIDS). Ann Intern Med 110: 335
42. Grunt TW, Lametschwadtner A, Karrer K (1986) The characteristic structural feature of the blood vessels of the Lewis lung carcinoma. Scanning Electron Microsc 11: 575
43. Grunt TW, Lametschwadtner A, Karrer K, Staindl O (1986) The angioarchitecture of the Lewis lung carcinoma in laboratory mice. Scanning Electron Microsc 11: 557
44. Haimovitz-Friedman A, Vlodavsky I, Chaudhuri A, Witte L, Fuks Z (1991) Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res 51: 2552
45. Hoffman MA, Wadler S (1993) Mechanisms by which interferon potentiates chemotherapy. Cancer Invest 11: 310
46. Ingber D, Folkman J (1988) Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest 59: 44
47. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348: 555
48. Ishikawa F, Miyazone K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin C-H (1989) Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557
49. Iwagaki H, Hizuta A, Yoshino T, Mannami T, Moriyasu F, Tanaka N, Orita K (1993) Complete regression of advanced liposarcoma of the anterior chest wall with interferon-alpha and tumor necrosis factor-alpha. Anticancer Res 13: 13
50. Kamei S, Okada H, Inoue Y, Yoshioka T, Ogawa Y, Toguchi H (1993) Antitumor effects of angiogenesis inhibitor TNP-470 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution. J Pharmacol Exp Ther 264: 469
51. Kanatani Y, Kasukabe T, Hozumi M, Motoyoshi K (1993) Genistein exhibits preferential cytotoxicity to a leukemogenic variant but induces differentiation of a non-leukemogenic variant of the mouse monocytic leukemia Mm cell line. Leuk Res 17: 847
52. Kimmelman D, Kirschner M (1987) Synergistic induction of mesoderm by FGF and TGF-beta and the identification of an mRNA coding for FGF in the early Xenopus embryo. Cell 51: 869
53. Klagsbrun M, D'Amore PA (1991) Regulators of angiogenesis. Annu Rev Physiol 53: 217
54. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Einer VM, Einer SG, Stricter RM (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798
55. Kondo K, Tsuneizumik, Watanabe T, Oishi M (1991) Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases. Cancer Res 51: 5398
56. Krishnan EC, Krishnan L, Jewell WR (1988) Immediate effect of irradiation on microvasculature. Int J Radiat Oncol Biol Phys 15: 147
57. Kull FC Jr, Brent DA, Parikh I, Cuatrecasas P (1987) Chemical identification of a tumor-derived angiogenic factor. Science 236: 843
58. Kusaka M, Sudo K, Fujita T, Marui S, Itoh F, Ingber D, Folkman J (1991) Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun 174: 1070
59. Lee K-E, Iwamura M, Cockett ATK (1990) Cortisone inhibition of tumor angiogenesis measured by a quantitative colorimetric assay in mice. Cancer Chemother Pharmacol 26: 461
60. Linassier C, Pierre M, Le Peco J-B, Pierre J (1990) Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem Pharmacol 39: 187
61. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327
62. Luger TA, Schwarz T (1990) Evidence for an epidermal cytokine network. J Invest Dermatol 95: 100S
63. Masferrer JL, Rimarachin JA, Gerrifsen ME, Falck JR, Yadagiri P, Dunn MW, Laniado SM (1991) 12(R)-hydroxyeicosatrienoic acid, a potent chemotactic and angiogenic factor produced by the cornea. Exp Eye Res 52: 417
64. McCabe MJ Jr, Orrenius S (1993) Genistein induces apoptosis in immature human thymocytes by inhibiting toposiomerase-II. Biochem Biophys Res Commun 194: 944
65. Merigan TC (1988) Human interferon as a therapeutic agent: a decade passes. New Engl J Med 318: 1458
66. Messina M, Barnes S (1991) The role of soy products in reducing risk of cancer. J Natl Cancer Inst 83: 541
67. Moses MA, Sudhalter J, Langer R (1990) Identification of an inhibitor of neovascularization from cartilage. Science 248: 1408
68. Murata J, Saiki I, Makabe T, Tsutu Y, Tokura S, Azuma I (1991) Inhibition of tumor-induced angiogenesis by sulfated chitin derivatives. Cancer Res 51: 22
69. Myoken Y, Kayada Y, Okamoto T, Kan M, Sato GH, Sato JD (1991) Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc Natl Acad Sci USA 88: 5819
70. Nagy JA, Brown LF, Senger DR, Lanir N, Van De Water L, Dvorak AM, Dvorak HF (1989) Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 948: 305
71. Nanus DM, Schmitz-Dräger BJ, Motzer RJ, Lee AC, Vlamis V, Cordon-Cardo C, Albino AP, Reuter VE (1993) Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J Natl Cancer Inst 85: 1597
72. O'Dell TJ, Kandel ER, Grant SGN (1991) Long-term potentiation in the hippocampus is blocked by tyrosin kinase inhibitors. Lett Nature 353: 558
73. Oikawa T, Hirotani K, Nakamura O, Shudo K, Hiragun A, Iwaguchi T (1989) A highly potent antiangiogenic activity of retinoids. Cancer Lett 48: 157
74. Oikawa T, Suganuma M, Ashino-Fuse H, Shimamura M (1992) Okadaic acid is a potent angiogenesis inducer. Jpn J Cancer Res 83: 6
75. Okamura K, Sato Y, Matsuda T, Hamanaka R, Ono M, Kohno K, Kuwano M (1991) Endogenous basic fibroblast growth factor-dependent induction of collagenase and interleukin-6 in tumor necrosis factor-treated human microvascular endothelial cells. J Biol Chem 266: 19162
76. Oliveira IC, Sciavolino PJ, Lee TH, Vilcek J (1992) Down-regulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc Natl Acad Sci USA 89: 9049
77. Orchard PJ, Smith III CM, Woods WG, Day DL, Dehner LP, Shapiro R (1989) Treatment of haemangioendotheliomas with alpha interferon. Lancet 2: 565
78. Pepper MS, Ferrara N, Orci L, Montesano R (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181: 902
79. Peterson G, Barnes S (1991) Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multidrug resistance gene. Biochem Biophys Res Commun 179: 661
80. Prionas SD, Kowalski J, Fajardo LF, Kaplan I, Kwan HH, Allison AC (1990) Effects of X-irradiation on angiogenesis. Radiat Res 124: 43
81. Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K, Tryggvason K (1992) Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 52: 1336
82. Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC, Miskin R (1988) Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48: 3307
83. Rifkin DB, Moscatelli D (1989) Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 109: 1
84. Rosenthal RA, Megyesi J, Henzel WJ, Ferrara N, Folkman J (1990) Conditioned medium from mouse sarcoma 180 cells contains vascular endothelial growth factor. Growth Factors 4: 53
85. Sakamoto N, Iwahana M, Tanaka NG, Osada Y (1991) Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide. CDPGYIGSR-NH2. Cancer Res 51: 903
86. Schoof DD, Obando JA, Cusack JC Jr, Goedegebuure PS, Brem H, Eberlein TJ (1993) The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro. Int J Cancer 55: 630
87. Sharpe RJ, Kadin ME, Harmon DC, Imber MJ, Anderson RR (1989) Complete resolution of Kaposi's sarcoma with systemic etretinate therapy in a patient with mycosis fungoides. J Am Acad Dermatol 20: 1123
88. Shing Y (1988) Heparin-copper biaffinity chromatography of fibroblast growth factors. J Biol Chem 263: 9059
89. Sidky YA, Borden EC (1987) Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 47: 5155
90. Slack JM, Darlington BG, Heath JK, Godsave SF (1987) Mesoderm induction in early Xenopus embryos by heparin-binding growth factors. Nature 326: 197
91. Sporn MB, Roberts AB (1990) Peptide growth factors. Springer, Berlin, p 419
92. Stein CA, LaRocca RV, Thomas R, McAtee N, Myers CE (1989) Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncol 7: 499
93. Stetler-Stevenson WG, Krutzsch HC, Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264: 17374
94. Takano S, Gately S, Neville M, Herblin WF, Gross JL, Brem S (1993) Suramin, an inhibitor of angiogenesis, suppresses endothelial cell growth, migration and plasminogen activator activity. Proc Am Assoc Cancer Res 34: 74
95. Takano S, Gately S, Neville ME, Herblin WF, Gross JL, Engelhard H, Perricone M, Eidsvoog K, Brem S (1994) Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Cancer Res 54: 2654
96. Takayamiya Y, Friedlander RM, Brem H, Malick A, Martuza RL (1993) Inhibition of angiogenesis and growth of human nerve sheath tumors by AGM-1470. J Neurosurg 78: 470
97. Tamargo RJ, Bok RA, Brem H (1991) Angiogenesis inhibition by minocycline. Cancer Res 51: 672
98. Teicher BA, Alvarez Sotomayor E, Huang ZD (1992) Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 52: 6702
99. Teicher BA, Alvarez Sotomayor E, Huang ZD, Ara G, Holden S, Khandekar V, Chen Y-N (1993) β-Cyclodextrin tetradecasulfate/tetrahydrocortisol ± minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma. Cancer Chemother Pharmacol 33: 229
100. Teicher BA, Holden SA, Ara G, Alvarez Sotomayor E, Huang ZD, Chen Y-N, Brem H (1994) Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other antiangiogenic agents. Int J Cancer 57: 920
101. Templeton NS, Stetler-Stevenson WG (1991) Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line. Cancer Res 51: 6190
102. Thorpe PE, Derbyshire EJ, Andrade SP, Press N, Knowles PP, King S, Watson GJ, Yang Y-C, Rao-Betté (1993) Heparin-steroid conjugates: new angiogenesis inhibitors with antitumor activity in mice. Cancer Res 53: 3000
103. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947
104. Toi M, Yamamolo Y, Imazawa T, Takayanagi T, Akutsu K, Tominaga T (1993) Antitumor effect of the angiogenesis inhibitor AGM-1470 and its combination effect with tamoxifen in DMBA induced mammary tumors in rats. Int J Oncol 3: 525
105. Toma S, Melioli G, Palumbo R, Rosso R (1993) Recombinant interleukin-2 and α-2a-interferon in pre-treated advanced soft tissue sarcomas. Int J Oncol 2: 997
106. Tryggvason K, Hoyhtya M, Salo T (1987) Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 907: 191
107. Van Hoef MEHM, Knox WF, Dhesi SS, Howell A, Schor AM (1993) Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 29A: 1141
108. Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M (1987) Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 84: 2292
109. Vlodavsky I, Korner G, Ishai-Michaeli R, Bashkin P, Bar-Shavit R, Fuks Z (1990) Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 9: 203
110. Reference deleted
111. Watanabe T, Kondo K, Oishi M (1991) Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases. Cancer Res 51: 764
112. Wei H, Wei L, Frenkel K, Bowen R, Barnes S (1993) Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 20: 1
113. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New Engl J Med 324: 1
114. Weidner N, Folkman J, Pozza F, Pierantonio B, Allred EN, Moore DH, Meli S, Gasparini G (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875
115. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL (1989) Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. Med Intelligence 18: 1197
116. White CW, Wolf SJ, Korones DN, Sondheimer HM, Tosi MF, Yu A (1991) Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a. J Pediatr 118: 59
117. Yamaoka M, Yamamoto T, Ikeyama S, Sudo K, Fujita T (1993) Angiogenesis inhibitor TN P-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res 53: 5233
118. Yamaoka M, Yamamoto T, Masaki T, Ikeyama S, Sudo K, Fujita T (1993) Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillin (TNP-470; AGM-1470). Cancer Res 53: 4262
119. Yamashita Y, Kawada S, Nakano H (1990) Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem Pharmacol 39: 737
120. Yanase T, Tamura M, Fujita K, Kodama S, Tanaka K (1993) Inhibitory effect of angiogenesis inhibitor TNP-470 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution. Cancer Res 53: 2566
121. Yayon A, Klagsbrun M (1990) Autocrine transformation by chimeric signal peptide-basic fobroblast growth factor: reversal by suramin. Proc Natl Acad Sci USA 87: 5346
122. Zwiller J, Sassone-Corsi P, Kakazu K, Boyton AL (1991) Inhibition of PDGF-induced c-jun and c-fos expression by a tyrosine protein kinase inhibitor. Oncogene 6: 219